Antisense compounds, compositions and methods are provided for modulating the expression of apolipoprotein B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding apolipoprotein B. Methods of using these compounds for modulation of apolipoprotein B expression and for treatment of diseases associated with expression of apolipoprotein B are provided. Methods are provided for modulating the expression of genes involved in lipid metabolism, useful in the treatment of conditions associated with cardiovascular risk. Antisense oligonucleotides targeted to apolipoprotein B reduce the level of apolipoprotein B mRNA, lower serum cholesterol and shift liver gene expression profiles from those of an obese animal towards those of a lean animal. Further provided are methods for improving the cardiovascular risk of a subject through antisense inhibition of apolipoprotein B. Also provided are methods for employing antisense oligonucleotides targeted to apolipoprotein B to modulate a cellular pathway or metabolic process.
提供了用于调节
载脂蛋白B表达的反义物质、组合物和方法。这些组合物包括针对编码
载脂蛋白B的核酸的反义物质,特别是反义寡核苷酸。提供了使用这些化合物调节
载脂蛋白B表达并治疗与
载脂蛋白B表达相关疾病的方法。提供了用于调节涉及脂质代谢的
基因表达的方法,可用于治疗与心血管风险相关的疾病。针对
载脂蛋白B的反义寡核苷酸降低了
载脂蛋白B mRNA
水平,降低了血清
胆固醇水平,并将肝脏
基因表达谱从肥胖动物的表达谱转变为瘦小动物的表达谱。此外,还提供了通过反义抑制
载脂蛋白B来改善受试者心血管风险的方法。还提供了使用针对
载脂蛋白B的反义寡核苷酸调节细胞通路或代谢过程的方法。